Skip to content
Back to glossary
Therapeutics

Berberine

DEBerberin

Berberine is an isoquinoline alkaloid found in multiple plant genera, including Berberis, Hydrastis canadensis (goldenseal), and Coptis chinensis. It is sold as a dietary supplement in most jurisdictions and is not an approved drug in the EU or US. Berberine inhibits mitochondrial complex I, raising the AMP:ATP ratio and thereby activating AMPK downstream; small trials show modest reductions in fasting glucose, HbA1c, LDL cholesterol, and triglycerides in metabolic syndrome and type 2 diabetes. Marketed informally as natural metformin, evidence quality is limited, product purity varies, and CYP3A4-mediated drug interactions warrant caution. Longevity use is investigational.

Last reviewed:

Sources

  1. Zhang Y, Li X, Zou D et al.. (2008). Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. *Journal of Clinical Endocrinology & Metabolism*doi:10.1210/jc.2007-2404
  2. Lee YS, Kim WS, Kim KH et al.. (2006). Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. *Diabetes*doi:10.2337/db06-0006